{"name":"ZEO ScientifiX, Inc.","slug":"zeo-scientifix-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":5199000,"revenueGrowth":12.5,"grossMargin":82.1,"rdSpend":100000,"netIncome":-5521000,"cash":108570,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zofin","genericName":"Zofin","slug":"zofin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Zofin","genericName":"Zofin","slug":"zofin","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNNHhIYlBLcEtVTHFqQThDTnRFNzhqNEY4VE92TGdPQkg3dEh0U0syNVJSZVZxR0JRV3hkN3dueHRXc203dWREZXdBalk3eDQwNjVXR0Z5bkRXcFRVb3J0VFJ1Mjc0WE5hZ1E4SlljRmx2Nk1kby1wWEpyUVlfVTlwQ2RQbzJfTUYtdTdzTDhvZDBDVnhBUXgxM09kMG1jMnNoLVlhOE9mNUNFS25PNXFEZjhTZ1kzZmlyNzhxYzZoOGRyaFNta3k1c1NNdnhsdkE4ejltMWlRaUIyNlFFX05tZUpZTV8?oc=5","date":"2026-04-07","type":"pipeline","source":"ACCESS Newswire","summary":"ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage - ACCESS Newswire","headline":"ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage","sentiment":"neutral"},{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNbG1COEdSbFNzOE05Z0dOODhBaFVvMUNqSTluVHdHS21Ld2RmUXZldjNHLVZHQVBiUXdMdkFLUnY3bWh2VjNiRnRsbmhqZkYteWJaU1VLdVZNbEU5T0F6eHlpeG1SSDVrWUZSQUZNbmRWdll2U2h4eWxydGZkRjkzVlc5dXlmaWNsa1pyS0FtWlRzVjdfQ3d3ejYxdzZQeTNpWWFSOXliUVl6d1hXc0NkV2Z4X2E4NXFfNHJqRFVTeDI2bjAzX1FmWVYwaWlsV3F0dmZZcG5xcXU0WUtKbmJmZlBZVnF6UXdtcUJr?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Rett Syndrome Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight","sentiment":"neutral"},{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5SYzk1VmgxOFpNTE0zY2oyUXBfUTJjYmQ0dmM0YjlDRTg1N3dVYTVGRGJKdnpMMzFjbFJDcnBTeUVMMm55bk9Ed0R5VGlPUUZOU2VhNnln?oc=5","date":"2026-02-14","type":"pipeline","source":"Stock Titan","summary":"ZEOX Financials: Income Statement, Balance Sheet & Cash Flow | ZEO ScientifiX - Stock Titan","headline":"ZEOX Financials: Income Statement, Balance Sheet & Cash Flow | ZEO ScientifiX","sentiment":"neutral"},{"date":"2026-01-29","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-01-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxONnJ3UmR1cGd4Tm9LblYwelpQZmhGZFJ2M2l5MkY2Um90Uzl6Ym9oRk1BbWJQWU5QUVhMdEFmeVdPVkszeHEyWlVTa053U05aOU5DOW8xMldrcUcxLWktUHhJZHBTRC1uQ3V5TVVsRUc1ZkhFMFRObm9fem9oelZ5eWpKUTRQZzNzajJtcktTbE1yN3pENVRJdDhGUUV6U18tWEc3amJTaHRBZmRacHNnZFB3MGN0aXdzTmlHdEhwa0pvbTVMdklnc0JaZVFFTHBtU1NCUm5WS2k5LW1DLVprNHUyMWdIMXhmOVVfcldLRG5RZVRxdGpxeldCMnR4ZkZocEw2UHN3V2otU0pfR0VQR0h3TVYyOFppdTNZc2x6UjJhLU01UWJBUGU5MTJDNkxjdkFab25lS2Nwek4ycjd2VFdRTW0?oc=5","date":"2026-01-07","type":"deal","source":"PR Newswire","summary":"Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States - PR Newswire","headline":"Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's ","sentiment":"neutral"},{"date":"2026-01-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPLTJGdnczd01tZGE3Vk5NdlRJbUVQbkdaMTh1ZmVSckZncUR5bktZazA1ZmdKaWFldmJHU1ZaTUdVOXlLWjRSbE5jd1hlcnFnSndlZ0hTaTRWaERSRjBKSXRNNHVVWWg5TWo0QXowVDZRUXVTd2lfd09SZFdIcjNiR21nbWQ0OElKSHZaZkxWWDM1U1VoMTNxSVBiRjVSeFdpeENsUTlReU1QdVRLaUE?oc=5","date":"2025-10-30","type":"pipeline","source":"The Business Journals","summary":"Stem cell law positions Florida as regenerative medicine hot spot - South Florida Business Journal - The Business Journals","headline":"Stem cell law positions Florida as regenerative medicine hot spot - South Florida Business Journal","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":5199000,"revenuePeriod":"2025-10-31","revenueHistory":[{"value":5199000,"period":"2025-10-31"},{"value":4620000,"period":"2024-10-31"},{"value":4558278,"period":"2023-10-31"},{"value":6491008,"period":"2022-10-31"},{"value":5597487,"period":"2021-10-31"},{"value":3055776,"period":"2020-10-31"}],"grossProfit":4268000,"grossProfitHistory":[],"rdSpend":100000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5521000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":108570,"cashHistory":[],"totalAssets":1527000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}